Upstate New York LRIG

The Upstate New York LRIG is pleased to present a meeting and supplier exhibition that is free and open to the public.

This is an opportunity to meet your peers where the life sciences intersect with engineering and robotics.

Hear how automation is impacting the science of cell culturing (especially stem cells) from professionals actively involved in the field.

Meet suppliers of some of the most advanced life-science automation available.

"GNF Systems Automated Cell Culture and Integration into High Throughput Screening and Protein Purification Systems"

Daniel Rines, Research Investigator, Genomics Institute of the Novartis Research Foundation (GNF), San Diego, CA

Daniel Rines is a Research Investigator with the Genomics Institute of the Novartis Research Foundation (GNF). He joined GNF in 2004 as a Postdoctoral Fellow and subsequently went on to initiate and head a bio-imaging program focused on image-based screening, also known as high-content screening (HCS). His group has the responsibility for applying HCS to small molecule drug discovery and genomic target identification efforts. In addition, he works closely with the engineering group at GNF to develop new screening platforms and technologies. Prior to working at GNF he received a BS in Biochemistry at the University of California (Davis) and a PhD in molecular and cellular biology from M.I.T. He received fellowships from the Howard Hughes Medical Institutes (HHMI). Before embarking on a research career Dan worked in the software industry for nine years developing graphics and image analysis applications for Adobe Systems and also co-founded AppSoft.

David W. Andrews PhD, Professor, Biochemistry and Biomedical Sciences, Canada Research Chair in Membrane Biogenesis, McMaster University, Hamilton, ONT

Currently Dr. Andrews holds a Canada Research Chair in Membrane Biogenesis and is Director of the McMaster Biophotonics Facility which he founded 2 years ago and Co-director of the McMaster Stem Cell Library. He has published >80 original research papers in peer reviewed journals. He publishes in the top journals in the areas of Biochemistry, Cell and Molecular Biology, including journals such as Cell, Mol. Cell, Nature Medicine and EMBO J. He holds grants from the CIHR, US DoD, CBCRA, OICR etc. Dr. Andrews has served as President Canadian Federation of Biological Societies and of the Canadian Society of Biochemistry, Molecular and Cellular Biology. He provides service to a number of journals including a term on the editorial board of The Journal of Biological Chemistry, he is currently a contributing member of the Faculty of 1000 (www.facultyof1000.com) and is on the editorial board of BMC Cell Biology. He has served on a number of grant review panels in the US and Canada including the CIHR Team Grants panel, the US Department of Defence, Breast Cancer Research Program, NIH, and is a member of the Canada Research Chairs Program College of Reviewers. Dr. Andrews is also active in the private sector where he was a founding partner in MBI Fermentas and a member of the Scientific Advisory Board of Isogenica Ltd., Cambridge, England. He is currently involved in research projects with ThermoFisher, PerkinElmer and Spectral Applied Research.

www.dwalab.ca

www.macbiophotonics.ca

"A Fully Automated Workflow Integrating Data Driven Cell Culture and Imaging for Monoclonal Antibody Development Using Velocity 11's BioCel Systems"

Denise Williams is the Integrated Systems Program Manager for Velocity 11, The Automated Solutions Division of Agilent. She joined Velocity 11 in March 2008 as Director of Applications after serving as the Director of Research Automation Services at Medarex, Inc. At Medarex, implemented automation systems focused on cell culture, screening, cell imaging, and genotyping. Denise will speak both about her experiences at Medarex as an end-user of cell-based automation and her new role at Director of Applications at Velocity 11.

"Of Cells and Automation: A Perspective on Harnessing Cell Dynamics in the Automated HTS Environment"

Christopher Hogan, Scientist, Lead Discovery, Novartis Institutes for BioMedical Research, Inc., Cambridge, MA 02139

Chris Hogan worked in the Oncology department at Millennium Pharmaceuticals as a cell biologist developing somatic cell knock outs and reporter cell lines for profiling novel protein functions. Chris has been with the Novartis Institutes of Biomedical Research in Cambridge MA for the past five years where he helped set up a cellular
resources group centered around the TAP SelecT platform. His group supports all cell and membrane needs as part of HTS and preclinical profiling at the Cambridge facility. Though a cell biologist by training through undergraduate and graduate studies, Chris has assumed the roles of principle engineer, program designer, operator and others
for the SelecT instrument and has gained an appreciation of the relationship between cells and the automated universe in which they are harnessed, and how they can best be interfaced with downstream assay needs.

Thank You to the following for their support in helping to sponsor this meeting. Please be sure to visit our sponsors!